180 related articles for article (PubMed ID: 1982058)
1. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
[TBL] [Abstract][Full Text] [Related]
2. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
Kinter LB; Mann WA; Weinstock J; Ruffolo RR
Chirality; 1994; 6(5):446-55. PubMed ID: 7915128
[TBL] [Abstract][Full Text] [Related]
3. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
[TBL] [Abstract][Full Text] [Related]
4. Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.
Brooks DP; DePalma PD; Cyronak MJ; Bryant MA; Karpinski K; Mico B; Gaitanopoulos DE; Chambers PA; Erhard KF; Weinstock J
J Pharmacol Exp Ther; 1990 Sep; 254(3):1084-9. PubMed ID: 1975620
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
Hahn RA; Wardell JR; Sarau HM; Ridley PT
J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
Brooks DP; DePalma PD; Cyronak MJ; Karpinski K; Weinstock J
Pharmacology; 1990; 41(5):299-308. PubMed ID: 1982634
[TBL] [Abstract][Full Text] [Related]
8. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
Zhao RR; Wang PH; Zhang WF; Fennell WH
Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
Christie MI; Smith GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
[TBL] [Abstract][Full Text] [Related]
11. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat.
Van der Niepen P; Schoors DF; Dupont AG
Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774
[TBL] [Abstract][Full Text] [Related]
12. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
Hedge SS; Ricci A; Amenta F; Lokhandwala MF
J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
[TBL] [Abstract][Full Text] [Related]
13. Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526.
Ackerman DM; Blumberg AL; McCafferty JP; Sherman SS; Weinstock J; Kaiser C; Berkowitz B
Fed Proc; 1983 Feb; 42(2):186-90. PubMed ID: 6130004
[TBL] [Abstract][Full Text] [Related]
14. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Clark KL; Hilditch A; Robertson MJ; Drew GM
J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
Kopia GA; Valocik RE
J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
Edwards RM
Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
[TBL] [Abstract][Full Text] [Related]
18. Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia.
Aronson S; Goldberg LI; Glock D; Roth S; Moss J; Roizen MF
J Cardiothorac Vasc Anesth; 1991 Feb; 5(1):29-32. PubMed ID: 1678284
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
Brooks DP; Mitchell MP; Short BG; Ruffolo RR; Nichols AJ
J Pharmacol Exp Ther; 1991 Jun; 257(3):1243-7. PubMed ID: 1675291
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
